Tolle Theve

1.5k total citations · 1 hit paper
12 papers, 1.2k citations indexed

About

Tolle Theve is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Tolle Theve has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Cancer Research and 8 papers in Genetics. Recurrent topics in Tolle Theve's work include Breast Cancer Treatment Studies (9 papers), Estrogen and related hormone effects (8 papers) and Cancer Treatment and Pharmacology (5 papers). Tolle Theve is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Estrogen and related hormone effects (8 papers) and Cancer Treatment and Pharmacology (5 papers). Tolle Theve collaborates with scholars based in Sweden and United Kingdom. Tolle Theve's co-authors include Björn Cedermark, Lambert Skoog, Ulla Glas, J Askergren, Anders Somell, Nils Wilking, Claes Silfverswärd, Tommy� Fornander, Anders Mattsson and Lars Erik Rutqvist and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Tolle Theve

12 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS

1989 685 citations Tommy� Fornander, Björn Cedermark et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tolle Theve Sweden	10	723	515	461	242	184	12	1.2k
Anders Somell Sweden	11	625 0.9×	478 0.9×	506 1.1×	231 1.0×	174 0.9×	12	1.1k
J Askergren Sweden	15	705 1.0×	530 1.0×	492 1.1×	240 1.0×	192 1.0×	26	1.4k
J. Benraadt Netherlands	9	636 0.9×	233 0.5×	440 1.0×	372 1.5×	221 1.2×	13	1.3k
Tanja Ignatov Germany	22	534 0.7×	336 0.7×	507 1.1×	234 1.0×	182 1.0×	45	1.3k
Alwynne Tidy United Kingdom	11	1.2k 1.7×	604 1.2×	1.5k 3.2×	73 0.3×	65 0.4×	17	2.2k
M. Lassus Switzerland	12	671 0.9×	659 1.3×	720 1.6×	41 0.2×	37 0.2×	20	1.3k
Pamela Guglielmini Italy	13	595 0.8×	468 0.9×	577 1.3×	33 0.1×	52 0.3×	24	1.0k
Aman U. Budzar United Kingdom	4	1.1k 1.5×	801 1.6×	897 1.9×	65 0.3×	58 0.3×	4	1.6k
N. Wilking Sweden	5	307 0.4×	145 0.3×	189 0.4×	88 0.4×	72 0.4×	11	543
D. G. Kieback Germany	14	372 0.5×	393 0.8×	530 1.1×	81 0.3×	52 0.3×	31	946

Countries citing papers authored by Tolle Theve

Since Specialization

Citations

This map shows the geographic impact of Tolle Theve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tolle Theve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tolle Theve more than expected).

Fields of papers citing papers by Tolle Theve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tolle Theve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tolle Theve. The network helps show where Tolle Theve may publish in the future.

Co-authorship network of co-authors of Tolle Theve

This figure shows the co-authorship network connecting the top 25 collaborators of Tolle Theve. A scholar is included among the top collaborators of Tolle Theve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tolle Theve. Tolle Theve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Rutqvist, Lars Erik, Björn Cedermark, Ulla Glas, et al.. (1992). Randomized Trial of Adjuvant Tamoxifen in Node Negative Postmenopausal Breast Cancer. Acta Oncologica. 31(2). 265–270. 25 indexed citations

Fornander, Tommy�, L. E. Rutqvist, Björn Cedermark, et al.. (1991). Adjuvant tamoxifen in early-stage breast cancer: effects on intercurrent morbidity and mortality.. Journal of Clinical Oncology. 9(10). 1740–1748. 32 indexed citations

Rutqvist, L. E., Björn Cedermark, Ulla Glas, et al.. (1991). Contralateral Primary Tumors in Breast Cancer Patients in a Randomized Trial of Adjuvant Tamoxifen Therapy. JNCI Journal of the National Cancer Institute. 83(18). 1299–1306. 113 indexed citations

Rutqvist, Lars Erik, Björn Cedermark, Ulla Glas, et al.. (1990). Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer. Cancer. 66(1). 89–96. 33 indexed citations

Rutqvist, Lars Erik, Björn Cedermark, Tommy� Fornander, et al.. (1989). The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer.. Journal of Clinical Oncology. 7(10). 1474–1484. 36 indexed citations

Blomgren, Henric, et al.. (1989). Oral treatment with RU 41.740 (BiostimTM) in patients with advanced colorectal cancer: Influence on the blood lymphocyte population. International Journal of Immunopharmacology. 11(1). 71–76. 4 indexed citations

Rutqvist, Lars Erik, Björn Cedermark, Ulla Glas, et al.. (1989). Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials. International Journal of Radiation Oncology*Biology*Physics. 16(3). 629–639. 106 indexed citations

Fornander, Tommy�, Björn Cedermark, Anders Mattsson, et al.. (1989). ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS. The Lancet. 333(8630). 117–120. 685 indexed citations breakdown →

Rutqvist, L. E., Björn Cedermark, Ulla Glas, et al.. (1989). Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials. Maturitas. 11(3). 246–247. 1 indexed citations

10.

Rutqvist, Lars Erik, Björn Cedermark, Ulla Glas, et al.. (1987). The Stockholm trial on adjuvant tamoxifen in early breast cancer. Breast Cancer Research and Treatment. 10(3). 255–266. 98 indexed citations

11.

Lundell, G. E. F., Henric Blomgren, Björn Cedermark, et al.. (1984). High dose rDNA human alpha2 interferon therapy in patients with advanced colorectal adenocarcinoma: A phase II study. Radiotherapy and Oncology. 1(4). 325–332. 9 indexed citations

12.

Einhorn, Stefan, Jerzy Wasserman, G. E. F. Lundell, et al.. (1984). Treatment of patients with disseminated colorectal cancer with recombinant human alpha2-interferon. Studies on the immune system. International Journal of Cancer. 33(2). 251–256. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact